Class I anti-arrhythmic
This page covers all Class I anti-arrhythmic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium channels.
Targets
Phase 1 pipeline (1)
- Anti-Arrhythmic therapy · Imperial College London · Cardiovascular
Blocks potassium channels to prevent arrhythmias
Patent intelligence
- class i anti arrhythmic patent landscape — aggregated cliff calendar, attackable patents, originator estates